Danchen Gao,Anthony J. Hlinak,Ahmad M. Mazhary,James E. Truelove,Margaret B. Vaughn
申请号：
US14493921
公开号：
US09750756B2
申请日:
2014.09.23
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Pharmaceutical compositions are provided comprising one or more orally deliverable dose units, each comprising particulate celecoxib in an amount of about 10 mg to about 1000 mg in intimate mixture with one or more pharmaceutically acceptable excipients. The compositions are useful in treatment or prophylaxis of cyclooxygenase-2 mediated conditions and disorders.
